$0.61
-0.02(-2.55%)
Mkt Cap $6M
$0.59
$2.83
52-Week Range
At a Glance
AI-generatedNEXGEL delivered strong revenue growth and margin expansion through its consumer brand acquisitions, but persistent operating losses and negative cash flows raise substantial doubt about its ability to continue as a going concern.
8-K
NexGel, Inc. filed an 8-K on March 10, 2026, disclosing entry into an Asset Purchase and Exclusive License Agreement dated March 6, 2026, with Celularity and issuance of a related press release. The filing includes Exhibit 10.1, the agreement, under Item 9.01.$6M
Market Cap
$16M
Revenue
-$4M
Net Income
Employees19
Fundamentals
How The Business Makes Money
NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. NEXGEL, Inc. was founded in 1997 and is based in Langhorne, Pennsylvania.
Industry Medical - Instruments & Supplies
Activity
What Changed Recently
Analyst View
Company Profile
CIK0001468929
ISINUS65344E1073
CUSIP65344E107
Phone215 702 8550
Address2150 Cabot Boulevard West, Langhorne, PA, 19047, US
SEC EDGAR